Cholesterol induces renal vasoconstriction and anti-natriuresis by inhibiting nitric oxide production in anesthetized rats

1 Physiology, Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, New Orleans, Louisiana; ; 2 Physiology and Biophysics, SUNY at Buffalo, Buffalo, New York; and ; 3 Department for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American Journal of Physiology - Renal Physiology 2009-12, Vol.297 (6), p.F1606-F1613
Hauptverfasser: Kopkan, Libor, Khan, Md Abdul H, Lis, Agnieszka, Awayda, Mouhamed S, Majid, Dewan S. A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1 Physiology, Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, New Orleans, Louisiana; ; 2 Physiology and Biophysics, SUNY at Buffalo, Buffalo, New York; and ; 3 Department for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic Submitted December 12, 2008 ; accepted in final form September 16, 2009 Although hypercholesterolemia is implicated in the pathophysiology of many renal disorders as well as hypertension, its direct actions in the kidney are not yet clearly understood. In the present study, we evaluated renal responses to administration of cholesterol (8 µg·min –1 ·100 g body wt –1 ; bound by polyethylene glycol) into the renal artery of anesthetized male Sprague-Dawley rats. Total renal blood flow (RBF) was measured by a Transonic flow probe, and glomerular filtration rate (GFR) was determined by Inulin clearance. In control rats ( n = 8), cholesterol induced reductions of 10 ± 2% in RBF [baseline (b) 7.6 ± 0.3 µg·min –1 ·100 g –1 ], 17 ± 3% in urine flow (b, 10.6 ± 0.9 µg·min –1 ·100 g –1 ), 29 ± 3% in sodium excretion (b, 0.96 ± 0.05 µmol·min –1 ·100 g –1 ) and 24 ± 2% in nitrite/nitrate excretion (b, 0.22 ± 0.01 nmol·min –1 ·100 g –1 ) without an appreciable change in GFR (b, 0.87 ± 0.03 ml·min –1 ·100 g –1 ). These renal vasoconstrictor and anti-natriuretic responses to cholesterol were absent in rats pretreated with nitric oxide (NO) synthase inhibitor, nitro- L -arginine methylester (0.5 µg·min –1 ·100 g –1 ; n = 6). In rats pretreated with superoxide (O 2 – ) scavenger tempol (50 µg·min –1 ·100 g –1 ; n = 6), the cholesterol-induced renal responses remained mostly unchanged, although there was a slight attenuation in anti-natriuretic response. This anti-natriuretic response to cholesterol was abolished in furosemide-pretreated rats (0.3 µg·min –1 ·100 g –1 ; n = 6) but remained unchanged in amiloride-pretreated rats (0.2 µg·min –1 ·100 g –1 ; n = 5), indicating that Na + /K + /2Cl – cotransport is the dominant mediator of this effect. These data demonstrate that cholesterol-induced acute renal vasoconstrictor and antinatriuretic responses are mediated by a decrease in NO production. These data also indicate that tubular effect of cholesterol on sodium reabsorption is mediated by the furosemide sensitive Na + /K + /2Cl – cotransporter. cholesterol; nitric oxide; superoxide; epithelial Na + channel; Na + /K + /2Cl – cotransport; renal hemodynamics; sodium excret
ISSN:0363-6127
1931-857X
2161-1157
1522-1466
DOI:10.1152/ajprenal.90743.2008